Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
28.34
-0.07 (-0.25%)
Apr 26, 2024, 4:00 PM EDT - Market closed
IART Revenue
In the year 2023, Integra LifeSciences Holdings had annual revenue of $1.54B, a decrease of -1.03%. Revenue in the quarter ending December 31, 2023 was $397.04M, a -0.25% decrease year-over-year.
Revenue (ttm)
$1.54B
Revenue Growth
-1.03%
P/S Ratio
1.44
Revenue / Employee
$390,667
Employees
3,946
Market Cap
2.22B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
Dec 31, 2019 | 1.52B | 45.12M | 3.06% |
Dec 31, 2018 | 1.47B | 284.21M | 23.92% |
Dec 31, 2017 | 1.19B | 196.16M | 19.77% |
Dec 31, 2016 | 992.08M | 109.34M | 12.39% |
Dec 31, 2015 | 882.73M | 86.02M | 10.80% |
Dec 31, 2014 | 796.72M | 99.89M | 14.33% |
Dec 31, 2013 | 696.83M | -134.04M | -16.13% |
Dec 31, 2012 | 830.87M | 50.79M | 6.51% |
Dec 31, 2011 | 780.08M | 48.01M | 6.56% |
Dec 31, 2010 | 732.07M | 49.58M | 7.26% |
Dec 31, 2009 | 682.49M | 27.88M | 4.26% |
Dec 31, 2008 | 654.60M | 104.15M | 18.92% |
Dec 31, 2007 | 550.46M | 131.16M | 31.28% |
Dec 31, 2006 | 419.30M | 141.36M | 50.86% |
Dec 31, 2005 | 277.94M | 48.11M | 20.93% |
Dec 31, 2004 | 229.83M | 44.23M | 23.83% |
Dec 31, 2003 | 185.60M | 67.78M | 57.52% |
Dec 31, 2002 | 117.82M | 24.38M | 26.09% |
Dec 31, 2001 | 93.44M | 21.79M | 30.42% |
Dec 31, 2000 | 71.65M | 28.77M | 67.11% |
Dec 31, 1999 | 42.88M | 25.32M | 144.15% |
Dec 31, 1998 | 17.56M | 2.82M | 19.09% |
Dec 31, 1997 | 14.75M | 1.60M | 12.15% |
Dec 31, 1996 | 13.15M | 2.92M | 28.54% |
Dec 31, 1995 | 10.23M | 1.57M | 18.10% |
Dec 31, 1994 | 8.66M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teladoc Health | 2.60B |
ICU Medical | 2.26B |
Privia Health Group | 1.66B |
Tandem Diabetes Care | 747.72M |
Inari Medical | 493.63M |
STAAR Surgical Company | 322.42M |
TG Therapeutics | 233.66M |
Vericel | 197.52M |
IART News
- 9 days ago - Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 - GlobeNewsWire
- 26 days ago - Integra LifeSciences Completes the Acquisition of Acclarent, Inc. - GlobeNewsWire
- 4 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART - PRNewsWire
- 6 weeks ago - Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases - GlobeNewsWire
- 7 weeks ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March - Ironwood Pharmaceuticals (NASDAQ:IRWD), Integra Lifesciences (NASDAQ:IART) - Benzinga
- 2 months ago - Integra LifeSciences Announces Leadership Transition Plan - GlobeNewsWire
- 2 months ago - Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance - GlobeNewsWire
- 2 months ago - Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024 - GlobeNewsWire